5-amino-1mq human trials Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice 5-Amino-1MQ NNMT Inhibitor for Research

At the 1 mg dose, subjects lost a mean of approximately 2.8 kg versus 0.8 kg in the placebo group over 12 weeks, a difference that reached statistical significance [1]

Speak with a licensed medical provider before beginning any peptide protocol

The copper chelation capacity of AHK-Cu distinguishes it from unchelated peptide analogs, enabling research into coppers role as a cofactor in angiogenic and wound-response signaling

There is also the slight risk of nerve injury with IM shots

Combining the two: the practical protocol Here is where the combination protocol differs from running either compound alone

Rub injection site in circular motion